The development of TAAR1 ligands represents an intriguing strategy for the treatment of several disorders including schizophrenia, depression, attention deficit hyperactivity disorder, Parkinson’s disease, addiction, and metabolic diseases [22]. The gene discussed is TAAR1; the disease is depressive disorder.